Nathaniel Weygant

Fujian University of Traditional Chinese Medicine

Also affiliated with Beijing Chaoyang Emergency Medical Center

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment”.

Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment

Cancers(2020)10.3390/cancers12123801

N/A

0.571DataRank · unranked

44 citations

Nathaniel Weygant, Parthasarathy Chandrakesan, Courtney W. Houchen, Jun Peng, Dongfeng Qu +1 more

Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments

Cancers(2020)10.3390/cancers12020274

N/A

0DataRank · unranked

84 citations

Dongfeng Qu, Nathaniel Weygant, Jun Peng, Courtney W. Houchen, Xiangyan Wu

DCLK1-Isoform2 Alternative Splice Variant Promotes Pancreatic Tumor Immunosuppressive M2-Macrophage Polarization

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0776

N/A

0DataRank · unranked

35 citations

Janani Panneerselvam, Randal May, Nathaniel Weygant, Dongfeng Qu, William L. Berry +6 more